Clinical trial
Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients…
NCT00344487 · University of Maryland, Baltimore, Other · Terminated
Key facts
| NCT number | NCT00344487 |
|---|---|
| Title | Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study |
| Official title | The Effect of Kaletra on CD4 Immune Reconstitution in HIV-infected Patients With Long-term Virologic Suppression on a Non-Kaletra Containing ART Regimen, But With a Blunted Immune Response |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug |
| Interventions | Lopinavir/Ritonavir |
| Enrollment | 3 |
| Start date | Dec 1, 2005 |
| Primary completion | May 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jun 26, 2006 |
| Last update posted | Jan 24, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: